Summary
Dr. Gunter is Chair in Cancer Epidemiology and Prevention in the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College. He is a molecular epidemiologist and his main research focus is the role of metabolic and endocrine pathways in cancer development and prognosis.
Examples of current research projects include:
- PROMINENT (https://cancergrandchallenges.org/teams/prominent)
- DISCERN (Discovering the Causes of three poorly understood cancers in Europe; EU Cancer Mission) - https://www.iarc.who.int/news-events/discern-project-iarc-and-partners-search-for-unknown-causes-of-renal-pancreatic-and-colorectal-cancers
- Metabolomic Profiling and Colorectal Cancer Development
- Steroid hormones, insulin and insulin-like growth factors in endometrial cancer prognosis
- Diabetes and Cancer Initiative
- European Prospective Investigation into Cancer (EPIC)
Dr Gunter is a senior editor for Cancer Prevention Research https://aacrjournals.org/cancerpreventionresearch and a peer reviewer for numerous other scientific and medical journals
Education and Professional Employment
Oct 1994-July 1998 University of Oxford, B.A. Hons. Biochemistry
Oct 1998-May 2003 University of Cambridge, Ph.D. Molecular Epidemiology
Dec 2003-Dec 2005 National Cancer Institute, NIH, DHHS, USA; Post-doctoral fellow, Division of Cancer Epidemiology and Genetics
Dec 2005-Aug 2011 Albert Einstein College of Medicine, New York, USA; Department of Epidemiology and Population Health; 2005-2007, Instructor; 2007-2011, Assistant Professor
Sep 2011-Jan 2016 Imperial College London, Department of Epidemiology and Biostatistics, School of Public Health; Reader in Cancer Epidemiology
Feb 2016-Jan 2023 International Agency for Research on Cancer (IARC-WHO), Head, Nutrition and Metabolism Branch
March 2023 - Imperial College London, Department of Epidemiology and Biostatistics, School of Public Health; Professor and Chair in Cancer Epidemiology and Prevention
Selected Publications
Journal Articles
Gunter MJ, Hoover DR, Yu H, et al., 2009, Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women, Journal of the National Cancer Institute, Vol:1, Pages:48-60